We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPZM
7401
CALL
DELISTED
Epizyme, Inc
EPZM
-27,000
Closed -$366K
EPZM
7402
PUT
DELISTED
Epizyme, Inc
EPZM
-27,000
Closed -$366K
OBCI
7403
DELISTED
Ocean Bio-Chem Inc
OBCI
$0 ﹤0.01%
+4
New +$16
ACC
7404
CALL
DELISTED
American Campus Communities, Inc.
ACC
-1,500
Closed -$64K
CDK
7405
CALL
DELISTED
CDK Global, Inc.
CDK
-3,600
Closed -$234K
SRRA
7406
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
0
COHR
7407
CALL
DELISTED
Coherent Inc
COHR
-10,000
Closed -$1.56M
COHR
7408
PUT
DELISTED
Coherent Inc
COHR
-30,000
Closed -$4.69M
NSEC
7409
DELISTED
National Security Group Inc
NSEC
$0 ﹤0.01%
+2
New +$31
RENO
7410
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$0 ﹤0.01%
+13
New +$48
WVFC
7411
DELISTED
WVS Financial Corp
WVFC
$0 ﹤0.01%
+5
New +$82
HSTO
7412
DELISTED
Histogen Inc. Common Stock
HSTO
-269
Closed -$230K
ESBK
7413
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$0 ﹤0.01%
+4
New +$82
HBP
7414
DELISTED
Huttig Building Products, Inc.
HBP
-200
Closed -$1K
VOLT
7415
DELISTED
Volt Information Sciences, Inc.
VOLT
$0 ﹤0.01%
+33
New +$119
PBCT
7416
CALL
DELISTED
People's United Financial Inc
PBCT
-1,100
Closed -$20K
RESN
7417
DELISTED
Resonant Inc.
RESN
$0 ﹤0.01%
+89
New +$419
ARNA
7418
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
-30,000
Closed -$1.31M
RDS.B
7419
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-13,115
Closed -$953K
TGP
7420
CALL
DELISTED
Teekay LNG Partners L.P.
TGP
-1,100
Closed -$19K
ADXS
7421
DELISTED
Advaxis Inc
ADXS
$0 ﹤0.01%
2
-4,108
-100% -$80.1K
ENBL
7422
PUT
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
-15,700
Closed -$269K
ADMS
7423
PUT
DELISTED
Adamas Pharmaceuticals
ADMS
-100,000
Closed -$2.58M
XLRN
7424
PUT
DELISTED
Acceleron Pharma
XLRN
-33,000
Closed -$1.6M
LORL
7425
CALL
DELISTED
Loral Space and Communications, Inc.
LORL
-5,300
Closed -$199K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.